Does BLEOMYCIN Cause Malignant transformation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Malignant transformation have been filed in association with BLEOMYCIN (Bleomycin). This represents 0.1% of all adverse event reports for BLEOMYCIN.
9
Reports of Malignant transformation with BLEOMYCIN
0.1%
of all BLEOMYCIN reports
4
Deaths
3
Hospitalizations
How Dangerous Is Malignant transformation From BLEOMYCIN?
Of the 9 reports, 4 (44.4%) resulted in death, 3 (33.3%) required hospitalization.
Is Malignant transformation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does BLEOMYCIN Cause?
Off label use (656)
Febrile neutropenia (632)
Neutropenia (433)
Drug ineffective (395)
Pyrexia (291)
Product use in unapproved indication (280)
Pulmonary toxicity (263)
Thrombocytopenia (260)
Nausea (255)
Anaemia (252)
What Other Drugs Cause Malignant transformation?
OSIMERTINIB (109)
ETOPOSIDE (108)
MELPHALAN (95)
CYTARABINE (91)
CARMUSTINE (88)
CYCLOPHOSPHAMIDE (73)
PREDNISONE (69)
GEFITINIB (67)
VINCRISTINE (66)
DOXORUBICIN (61)
Which BLEOMYCIN Alternatives Have Lower Malignant transformation Risk?
BLEOMYCIN vs BLINATUMOMAB
BLEOMYCIN vs BLONANSERIN
BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLEOMYCIN vs BOCEPREVIR
BLEOMYCIN vs BOCOCIZUMAB